A team dedicated to reducing the risks of blood clots in patients during and after a stay in hospital has received a top UK accolade for their work.
Betsi Cadwaladr University Health Board was among the winners at the recent Anticoagulation Achievement Awards (AAA), held in the House of Parliament as part of World Thrombosis Day celebrations.
The team led by Nurse Christine Welburn, took ‘Best work in the prevention of hospital acquired thrombosis’.
The awards celebrate outstanding practice in the management, education and provision of anticoagulation services across the UK.
Across the UK there is historical challenges within hospital of poor compliance when completing risk assessment for venous thromboembolism, also known thrombosis or as ‘blood clots’ which includes ‘deep vein thrombosis’ and ‘pulmonary embolism’.
Venous thromboembolism (VTE) became a Tier 1 priority in Wales but change and improvement in practice heavily relied upon acknowledgement by local teams of the need to improve and how to achieve this across all departments in everyday practice.
In 2017, an audit carried out in Betsi Cadwaladr UHB showed only 34% compliance with competing VTE risk assessment on patients being admitted into hospital.
With training and planning to improve understanding, the multi-discipline team successfully upskilled all staff to implement routine VTE risk assessment for all patients and support on-going management for those found to be at risk.
By year end 2018, there a new audit showed a 100% compliant rate for carrying out VTE risk assessments and 100% compliant rate for subsequent appropriate management, it could not have been better news!’
Christine, Glan Clwyd Hospital’s Thromboprophylaxis Specialist Nurse said: “We are delighted to win the award as it’s a representation of all the hard work by our clinicians in the prevention of hospital acquired Thrombosis (HATs).
“All of us are really proud to receive this national accolade and we intend to use this to support our continued drive to improve this work and also share practice nationally.
Amir Hanna, Consultant Orthopaedic Surgeon and Clinical Lead for Thromboprophylaxis added: “I am very proud that the team’s hard work has been recognised by this award.
“The multi-disciplinary approach has been the key to its success and I look forward to continue working side by side with our Thromboprophylaxis nurses to build even further on what we have achieved.”
As the AAA Judging Panel commented, “The team’s work has brought very clear benefit to all patients, and reduced incidence of hospital acquired thrombosis as well as reduced cost to the Health Board.
“1 in 4 people worldwide die of conditions caused by blood clots, also known by the medical term “thrombosis”– the underlying cause of the world’s top three cardiovascular killers: heart attack, stroke and venous thromboembolism (VTE).